Jian Min Fang
Chief Executive Officer chez REMEGEN CO., LTD.
Fortune : 84 M $ au 31/03/2024
Profil
Jian Min Fang a fondé RemeGen Co., Ltd. et MabPlex International Ltd. Le Dr Fang est président de MabPlex International Ltd. et directeur général, directeur exécutif et directeur scientifique de RemeGen Co., Ltd. Le Dr Fang est également membre du conseil d'administration de l'Association pharmaceutique chinoise, de Remegen Medical Research Shanghai Co. Ltd, Remegen Biosciences, Inc. et Remegen Hong Kong Ltd. et vice-président de la division des médicaments anticorps de la China Medicinal Biotech Association. Le Dr Fang a obtenu un doctorat de l'université Dalhousie.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REMEGEN CO. LTD. CLASS H
12,79% | 01/10/2023 | 24 244 500 ( 12,79% ) | 84 M $ | 31/03/2024 |
Postes actifs de Jian Min Fang
| Sociétés | Poste | Début |
|---|---|---|
| REMEGEN CO., LTD. | Chief Executive Officer | 04/07/2008 |
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Founder | 25/06/2013 |
| Remegen Medical Research Shanghai Co. Ltd. | Director/Board Member | - |
| Remegen Biosciences, Inc. | Director/Board Member | - |
| Remegen Hong Kong Ltd. | Director/Board Member | - |
| Chinese Pharmaceutical Association | Director/Board Member | - |
| China Medicinal Biotech Association | Corporate Officer/Principal | - |
Formation de Jian Min Fang
| Dalhousie University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REMEGEN CO., LTD. | Health Technology |
| Entreprise privées | 6 |
|---|---|
| Chinese Pharmaceutical Association | |
| China Medicinal Biotech Association | |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
| Remegen Medical Research Shanghai Co. Ltd. | |
| Remegen Biosciences, Inc. | |
| Remegen Hong Kong Ltd. |
